Kiniksa Pharmaceuticals International, plc Finite-Lived Intangible Asset, Expected Amortization, Year One
Kiniksa Pharmaceuticals International, plc (KNSA) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $1.00 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-24
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.00M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.00M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.00M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $1.00M 10-K · filed 2026-02-24 |
| 2024-12-31 | $1.00M 10-K · filed 2025-02-25 |
| 2023-12-31 | $1.00M 10-K · filed 2024-02-28 |
| 2022-12-31 | $1.00M 10-K · filed 2023-03-02 |
| 2021-12-31 | $1.00M 10-K · filed 2022-02-24 |
| 2021-09-30 | $1.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.00M 10-Q · filed 2021-05-06 |